Boulogne Billancourt, France

Gerard Duret

This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire L. Lafon. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerard Duret. Retrieved from https://idiyas.com/inventor/gerard-duret-3g003dc3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerard Duret: Innovator in Therapeutic Chemistry

Introduction

Gerard Duret is a notable inventor based in Boulogne Billancourt, France. He has made significant contributions to the field of therapeutic chemistry, particularly through his innovative work on 1,4-dihydropyridine derivatives. His research has implications for various therapeutic applications, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Gerard Duret holds 1 patent for his invention related to 1,4-dihydropyridine derivatives and their use in therapy. This patent reflects his commitment to developing new therapeutic agents that can improve patient outcomes.

Career Highlights

Duret is associated with Laboratoire L. Lafon, where he has been instrumental in research and development. His work at this esteemed laboratory has allowed him to explore innovative solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Gerard Duret has collaborated with esteemed colleagues such as Gerard Glauert and Marguerite Henry. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Gerard Duret's contributions to therapeutic chemistry through his patent and collaborative efforts highlight his role as an influential inventor in the field. His work continues to inspire advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…